NEW YORK (GenomeWeb) – Oxford BioDynamics announced today that it has signed a collaboration agreement with Holos Life Sciences to develop non-invasive epigenetic biomarkers linked to sports-related concussions.

Under the terms of the agreement, Holos will supply the participants' blood samples, while Oxford will provide its EpiSwitch platform and methodology for the development, evaluation, and validation of epigenetic biomarkers. The test's biomarker readouts will be based on minimally invasive blood testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.